These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1755767)

  • 21. Breast Cancer Chemoprevention in an Integrated Health Care Setting.
    Nichols HB; Stürmer T; Lee VS; Anderson C; Lee JS; Roh JM; Visvanathan K; Muss H; Kushi LH
    JCO Clin Cancer Inform; 2017 Nov; 1():1-12. PubMed ID: 30657366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of breast cancer using SERMs.
    Powles TJ
    Adv Exp Med Biol; 2008; 630():232-6. PubMed ID: 18637495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review of LHRH agonists for the adjuvant treatment of early breast cancer.
    Sharma R; Beith J; Hamilton A
    Breast; 2005 Jun; 14(3):181-91. PubMed ID: 15927827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.
    Kinsinger LS; Harris R; Woolf SH; Sox HC; Lohr KN
    Ann Intern Med; 2002 Jul; 137(1):59-69. PubMed ID: 12093250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors and the prevention of breast cancer with tamoxifen.
    Morrow M; Jordan VC
    Cancer Surv; 1993; 18():211-29. PubMed ID: 8012998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant endocrine therapy for premenopausal women with hormone-responsive breast cancer.
    Mathew A; Davidson NE
    Breast; 2015 Nov; 24 Suppl 2():S120-5. PubMed ID: 26255743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.
    Powles T; Eeles R; Ashley S; Easton D; Chang J; Dowsett M; Tidy A; Viggers J; Davey J
    Lancet; 1998 Jul; 352(9122):98-101. PubMed ID: 9672274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer prevention.
    Powles TJ
    Oncologist; 2002; 7(1):60-4. PubMed ID: 11854547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal approaches to breast cancer treatment and prevention: an overview.
    Vogel CL
    Semin Oncol; 1996 Aug; 23(4 Suppl 9):2-9. PubMed ID: 8824459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen--the treatment of choice. Why look for alternatives?
    Baum M
    Br J Cancer; 1998 Sep; 78 Suppl 4(Suppl 4):1-4. PubMed ID: 9741780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 14. Breast cancer prevention.
    Salih AK; Fentiman IS
    Int J Clin Pract; 2002 May; 56(4):267-71. PubMed ID: 12074209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.
    Crowell EB; Jubelirer SJ
    W V Med J; 2000; 96(6):598-601. PubMed ID: 11194088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the role of ovarian ablation in the management of primary and metastatic breast cancer today?
    Prowell TM; Davidson NE
    Oncologist; 2004; 9(5):507-17. PubMed ID: 15477635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of the main outcomes in breast-cancer prevention trials.
    Cuzick J; Powles T; Veronesi U; Forbes J; Edwards R; Ashley S; Boyle P
    Lancet; 2003 Jan; 361(9354):296-300. PubMed ID: 12559863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.
    Nourmoussavi M; Pansegrau G; Popesku J; Hammond GL; Kwon JS; Carey MS
    Cancer Treat Rev; 2017 Apr; 55():26-35. PubMed ID: 28288389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.
    Cuzick J; Forbes J; Edwards R; Baum M; Cawthorn S; Coates A; Hamed A; Howell A; Powles T;
    Lancet; 2002 Sep; 360(9336):817-24. PubMed ID: 12243915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of risk determinants for different breast cancer prevention strategies.
    Dowsett M
    Eur J Cancer; 2000 Jun; 36(10):1283-7. PubMed ID: 10882867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.
    Fabian CJ; Kimler BF
    Ann N Y Acad Sci; 2001 Dec; 952():44-59. PubMed ID: 11795443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.